Document is current

Article History

Accepted: 5 July 2022

First Online: 12 August 2022

Declarations

:

: This study was supported through internal seed funding from the Li Ka Shing Faculty of Medicine, The University of Hong Kong. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.

: EWC has received research grants from the Research Grants Council (RGC, Hong Kong), Narcotics Division of the Security Bureau of the Government of the Hong Kong SAR, Research Fund Secretariat of the Food and Health Bureau, National Natural Science Fund of China, Wellcome Trust, Bayer, Bristol-Myers Squibb, Pfizer, Janssen, Amgen, and Takeda, outside the submitted work. ICKW has received research grants from Research Grants Council (RGC, Hong Kong), Innovative Medicines Initiative (IMI), Shire, Janssen-Cilag, Eli-Lily, Pfizer, Bayer, and grants from European Union FP7 program, outside the submitted work. DCMK has sat on advisory boards for Becton Dickinson Pty Ltd and Merck Sharp & Dohme (MSD), and received financial support from MSD and F2G, outside the submitted work. MS has received grants from Gilead Sciences, Merck, F2G, and Pfizer unrelated to the submitted work. BJC has received funding from Sanofi Pasteur and Roche, outside the submitted work. The other author(s) declare no conflict of interest.

: EWC, SP, and VKCY conceptualized the study. EWC provided resources, acquired the data and supervised this study. SP and VKCY conducted analysis and formulated the original draft. All authors reviewed the manuscript critically and commented on manuscript drafts.

: Not applicable.

: Not applicable.

: Not applicable.

: Not applicable.

: Not applicable.

: Not applicable.